Serum preparations for inhibiting retroviruses and tumor growth
    131.
    发明申请
    Serum preparations for inhibiting retroviruses and tumor growth 审中-公开
    用于抑制逆转录病毒和肿瘤生长的血清制剂

    公开(公告)号:US20010043928A1

    公开(公告)日:2001-11-22

    申请号:US09790272

    申请日:2001-02-21

    Inventor: Mark E. Howard

    CPC classification number: C07K16/065 A61K38/00 A61K39/39516 C07K16/1036

    Abstract: Serum preparations obtained from sharks are used to prepare compositions, including pharmaceutical compositions, for inhibiting retrovirus replication in susceptible cells. Thus, the serum preparations are useful for inhibiting diseases associated with retroviral infection, such as acquired immunodeficiency syndrome. The serum concentrates are also used to inhibit growth of tumor cells, especially sarcomas and leukemias.

    Abstract translation: 使用从鲨鱼获得的血清制剂用于制备用于抑制易感细胞中逆转录病毒复制的组合物,包括药物组合物。 因此,血清制剂可用于抑制与逆转录病毒感染相关的疾病,例如获得性免疫缺陷综合征。 血清浓缩物也用于抑制肿瘤细胞,特别是肉瘤和白血病的生长。

    Monoclonal antibody immunoassay kit for avian reticuloendotheliosis virus
    136.
    发明授权
    Monoclonal antibody immunoassay kit for avian reticuloendotheliosis virus 失效
    用于禽网状内皮组织增生病毒的单克隆抗体免疫测定试剂盒

    公开(公告)号:US5130232A

    公开(公告)日:1992-07-14

    申请号:US536860

    申请日:1990-06-12

    CPC classification number: C07K16/1036 Y10S435/973 Y10S436/811

    Abstract: The combination of monoclonal antibodies 11A25 and 11E32, which recognize two distinct antigenic sites on the 62-kd glycoprotein of reticuloendotheliosis virus (REV) in ELISA, enables an increase in the sensitivity of an ELISA assay for subtype 2 REV over what was heretofore possible. The combination of MAbs is useful for diagnosing REV antigen and antibody in poultry flocks and for detecting new strains and variants of the viral subtype.

    Abstract translation: 在ELISA中识别网状内皮组织增生病毒(REV)的62-kd糖蛋白上的两个不同抗原位点的单克隆抗体11A25和11E32的组合使得能够增加针对亚型2 REV的ELISA测定的灵敏度比迄今为止可能的更高。 MAb的组合可用于诊断家禽群中的REV抗原和抗体,并用于检测病毒亚型的新菌株和变体。

    Antibodies to human leukemia virus-related peptides and a process for
production of the antibodies
    137.
    发明授权
    Antibodies to human leukemia virus-related peptides and a process for production of the antibodies 失效
    人类白血病病毒相关肽的抗体和抗体的制备方法

    公开(公告)号:US4804746A

    公开(公告)日:1989-02-14

    申请号:US713659

    申请日:1985-03-19

    Abstract: An antibody of a human leukemia virus-related peptide obtained by collecting an antibody produced in a mammal body by administering to the mammal an antigen prepared by reacting a human leukemia virus-related peptide selected from the group consisting of:(a) a peptide represented by formula (1):H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H (1)(b) a peptide represented by formula (2): psR-Ile-Pro-His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH (2)wherein R is the same as defined above;(c) a peptide represented by formula (3):R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH (3)wherein R is the same as defined above;(d) a peptide represented by formula (4):H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH (4)(e) a peptide represented by formula (5):R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH (5)wherein R is the same as defined above; and(f) a peptide represented by formula (6):H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH (6)as a hapten, with a carrier in the presence of a haptencarrier binding agent.

    Abstract translation: 通过对哺乳动物体内产生的抗体进行收集而获得的人类白血病病毒相关肽的抗体,其通过向哺乳动物施用通过使人白血病病毒相关肽反应而制备的抗原,所述人白血病病毒相关肽选自:(a) 式(1)表示的肽:H-Tyr-Val-Glu-Pro-Thr-Ala-Pro-Gln-Val-Leu-H(1)(b)由式(2)表示的肽:ps R-Ile-Pro -His-Pro-Lys-Asn-Ser-Ile-Gly-Gly-Glu-Val-OH(2)其中R与上述定义相同; (c)由式(3)表示的肽:R-Thr-Trp-Thr-Pro-Lys-Asp-Lys-Thr-Lys-Val-Leu-OH(3)其中R与上述定义相同; (d)由式(4)表示的肽:H-Val-Val-Gln-Pro-Lys-Lys-Pro-Pro-Pro-Tyr-OH(4)(e)由式(5)表示的肽: R-Met-Gly-Gln-Ile-Phe-Ser-Arg-Ser-Ala-Ser-Pro-OH(5)其中R与上述定义相同; 和(f)由式(6)表示的肽:作为半抗原的H-Tyr-Pro-Glu-Gly-Thr-Pro-Lys-Asp-Pro-Ile-Leu-Arg-Ser-Leu-OH 在载体中存在半载体结合剂。

Patent Agency Ranking